N-甲酰亚胺硫霉素与庆大霉素和阿米卡星对粪肠球菌的协同作用。
Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.
作者信息
Gombert M E, Berkowitz L B, Cummings M C
出版信息
Antimicrob Agents Chemother. 1983 Feb;23(2):245-7. doi: 10.1128/AAC.23.2.245.
Abstract
The in vitro activities of N-formimidoyl thienamycin alone and in combination with amikacin and gentamicin were tested against 10 strains of Streptococcus faecalis. Synergy was demonstrated in 35% of the combinations tested by the microtiter checkerboard technique; 50% were found to be synergistic with time killing curves.
摘要
单独使用N-甲酰亚胺硫霉素以及将其与丁胺卡那霉素和庆大霉素联合使用时，对10株粪链球菌进行了体外活性测试。通过微量滴定棋盘技术测试的组合中，35%表现出协同作用；通过时间杀菌曲线发现50%具有协同作用。
相似文献
1
Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.N-甲酰亚胺硫霉素与庆大霉素和阿米卡星对粪肠球菌的协同作用。
Antimicrob Agents Chemother. 1983 Feb;23(2):245-7. doi: 10.1128/AAC.23.2.245.
2
Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci.N-甲酰亚胺基硫霉素与庆大霉素或妥布霉素对肠球菌的协同作用。
Antimicrob Agents Chemother. 1982 Dec;22(6):1082-3. doi: 10.1128/AAC.22.6.1082.
3
In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.N-甲酰亚胺硫霉素（MK0787）联合阿米卡星对革兰氏阴性杆菌和金黄色葡萄球菌的体外评价
Antimicrob Agents Chemother. 1982 Dec;22(6):1064-6. doi: 10.1128/AAC.22.6.1064.
4
Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.亚胺培南与阿米卡星联合其他抗生素对星形诺卡菌的协同作用。
Antimicrob Agents Chemother. 1983 Nov;24(5):810-1. doi: 10.1128/AAC.24.5.810.
5
Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.亚胺培南（N-甲酰亚胺基硫霉素）对肠球菌的比较活性及其与氨基糖苷类药物的相互作用。
J Antimicrob Chemother. 1984 Feb;13(2):129-32. doi: 10.1093/jac/13.2.129.
6
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.新型β-内酰胺类药物与阿米卡星联合对铜绿假单胞菌、肺炎克雷伯菌和粘质沙雷菌的体外活性
Diagn Microbiol Infect Dis. 1983 Dec;1(4):287-93. doi: 10.1016/0732-8893(83)90004-4.
7
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.肠球菌和单核细胞增生李斯特菌对单独使用及与氨基糖苷类联合使用的N-亚胺基噻烯霉素的敏感性。
Antimicrob Agents Chemother. 1981 May;19(5):789-93. doi: 10.1128/AAC.19.5.789.
8
High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.用于确定氨基糖苷类药物与青霉素对粪肠球菌协同作用的高含量氨基糖苷类药敏纸片
J Clin Microbiol. 1988 Feb;26(2):257-60. doi: 10.1128/jcm.26.2.257-260.1988.
9
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.亚胺培南或青霉素G与氨基糖苷类药物对感染性心内膜炎患者分离出的肠球菌的协同作用。
Antimicrob Agents Chemother. 1984 Dec;26(6):909-12. doi: 10.1128/AAC.26.6.909.
10
Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin.粪肠球菌对抗生素协同作用的耐药性：用阿米卡星和一种新的阿米卡星衍生物4'-脱氧、6'-N-甲基阿米卡星进行的进一步研究
Antimicrob Agents Chemother. 1981 Apr;19(4):549-55. doi: 10.1128/AAC.19.4.549.
引用本文的文献
1
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
2
In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.亚胺培南对肠球菌和葡萄球菌的体外活性以及与替考拉宁、磷霉素和利福平有高协同率的证据。
Antimicrob Agents Chemother. 1986 Nov;30(5):813-5. doi: 10.1128/AAC.30.5.813.
本文引用的文献
1
Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.N-甲酰亚胺硫霉素对革兰氏阳性和革兰氏阴性需氧及厌氧菌的体外比较活性及其β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1982 Jan;21(1):180-7. doi: 10.1128/AAC.21.1.180.
2
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.N-甲酰亚胺硫霉素对肠球菌缺乏体内和体外杀菌活性。
Antimicrob Agents Chemother. 1982 Sep;22(3):448-52. doi: 10.1128/AAC.22.3.448.
3
Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.一种新型稳定化硫霉素（N-甲脒基硫霉素）与其他抗生素相比的抗菌活性。
Antimicrob Agents Chemother. 1980 Jun;17(6):912-7. doi: 10.1128/AAC.17.6.912.
4
In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.N-甲脒基硫霉素（MK0787）对铜绿假单胞菌、表皮葡萄球菌、粘质沙雷氏菌和肠球菌属耐药菌株的体外活性
Antimicrob Agents Chemother. 1981 Jan;19(1):114-6. doi: 10.1128/AAC.19.1.114.
5
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.N-甲酰亚胺硫霉素、哌拉西林、头孢噻肟和头孢哌酮的体外比较
Antimicrob Agents Chemother. 1981 Jul;20(1):140-3. doi: 10.1128/AAC.20.1.140.
6
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.与头孢噻肟、拉氧头孢和头孢他啶相比，N-甲酰亚胺硫霉素的体外活性。
Antimicrob Agents Chemother. 1981 Mar;19(3):402-6. doi: 10.1128/AAC.19.3.402.
7
A microdilution method for antibiotic susceptibility testing: an evaluation.一种用于抗生素敏感性测试的微量稀释法：一项评估。
Am J Clin Pathol. 1970 Jun;53(6):880-5. doi: 10.1093/ajcp/53.6.880.
8
Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.D组链球菌（肠球菌）对21种抗生素的体外敏感性，特别提及种间差异。
Am J Med Sci. 1969 Dec;258(6):416-30. doi: 10.1097/00000441-196912000-00006.
Zotero 插件